Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Tabarraee, Mahdi"'
Autor:
Tabarraee, Mahdi1, Rezaee, Atefeh2 atefehrezaee1981@gmail.com, Abolghasemi, Sara3, Ghadiany, Mojtaba1, Ardakani, MariaTavakoli4, Mahdizadeh, Mahshid4, Hamidi, Neda1, Ghasemi, Katayoon5
Publikováno v:
International Journal of Hematology-Oncology & Stem Cell Research. Jul2023, Vol. 17 Issue 3, p194-199. 6p.
Autor:
Ghadiany, Mojtaba, Tabarraee, Mahdi, Salari, Sina, Haghighi, Shirin, Rezvani, Hamid, Ghasemi, Seyedeh Najmeh, Karimi-Sari, Hamidreza
Publikováno v:
In Clinical Lymphoma, Myeloma and Leukemia April 2019 19(4):206-212
Autor:
Seifi, Sharareh, Fakhrai, Ghazal, Esfahani-Monfared, Zahra, Khosravi, Adnan, Abedini, Atefeh, Salimi, Babak, Seifi, Maryam, Tabarraee, Mahdi, Ghorbi, Mahmoud Dehghani
Publikováno v:
Tanaffos; 2023, Vol. 22 Issue 4, p411-417, 7p
Publikováno v:
Novelty in Biomedicine. 2020, Vol. 8 Issue 4, p151-155. 5p.
Autor:
Tavakoli, Azad1 Azadtavakoli@yahoo.co.uk, Tabarraee, Mahdi1, Tabeie, Faraj2, Mehdizadeh, Mahshid3,4, Ghadiani, Mojtaba1, Masoole, Leila Izadi5
Publikováno v:
Novelty in Biomedicine. 2020, Vol. 8 Issue 3, p125-128. 4p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mehdizadeh, Mahshid, Bolourian, Vahid, Zamani, Gholamreza, Tavakoli-Ardakanii, Maria, Zamani, Shayan, Tabarraee, Mahdi, Hajifathali, Abbas
Publikováno v:
International Journal of Hematology-Oncology & Stem Cell Research; Jan2022, Vol. 16 Issue 1, p55-65, 11p
Autor:
Tabarraee, Mahdi1, Tavakoli-Ardakani, Maria2 mariatavakoli@sbmu.ac.ir, Mehdizadeh, Mahshid3, Ghadiani, Mojtaba1, Rezvani, Hamid1, Hajifathali, Abbas3, khamsi, Samiyeh4
Publikováno v:
Iranian Journal of Pharmaceutical Research. 2016 Special Issue, Vol. 15, p159-163. 5p.
Autor:
Hajifathali, Abbas, Mehdizadeh, Mahshid, Vosoughi, Tina, Tabarraee, Mahdi, Talebi, Afshin, Sadegh Pezeshki, Seyed, Saki, Najmaldin, Hesam, Saeed, Salemzadeh, Molook
Publikováno v:
Clinical Cancer Investigation Journal; Jan/Feb2020, Vol. 9 Issue 1, p1-6, 6p
Autor:
Mohammad Javad Ebrahimi, Tabarraee Mahdi, Safari Shamsi, Reyhaneh Sadat Miri-Moosavi, Sara Boosaliki, Mirfakhraie Reza, Hamid Ghaedi, Riazi-Isfahani Sahand, Ghadyani Mojtaba, Omrani Mir Davood, Zare-Abdollahi Davood
Publikováno v:
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 37(8)
In acute myeloid leukemia (AML), despite the acceptance of standard intensive chemotherapy as an optimal induction regimen for all age groups, in the elderly patients, the best treatment should meet the challenge of multiple factors like age, comorbi